Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.200NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.299NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.55NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.149NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.300NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.179NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.125NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
G.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.438NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.178NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.208NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.197NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.491NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-2491.68Singapore
EV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.8 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.39.3 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.8.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.190NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.552NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.89NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
M.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.333NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.429NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.463NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
U.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.373NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.80NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.433NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.36.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.221.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.242NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.449NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.152NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.146NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
D.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.81NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.71NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.445NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.112NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used